Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies
Laura Breda, Valentina Ghiaccio, Naoto Tanaka, Danuta Jarocha, Yasuhiro Ikawa, Osheiza Abdulmalik, Alisa Dong, Carla Casu, Tobias Raabe, Xiaochuan Shan, Gwenn Danet-Desnoyers, Aoife Doto, J.K. Everett, Frederic D. Bushman, Enrico Radaelli, Charles A. Assenmacher, James C. Tarrant, Natalie Hoepp, Ryo Kurita, Yukio Nakamura, Virginia Guzikowski, Kim Smith‐Whitley, Janet L. Kwiatkowski, Stefano Rivella
Topics & Concepts
Genetic enhancementBiologyViral vectorGenome editingGenomeGeneGeneticsRecombinant DNAPrenatal Screening and DiagnosticsHemoglobinopathies and Related DisordersCRISPR and Genetic Engineering